These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26885127)

  • 1. Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.
    Erdem E
    Int J Clin Exp Med; 2015; 8(11):21689-93. PubMed ID: 26885127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
    Misra PS; Alam A; Lipman ML; Nessim SJ
    BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors.
    Alhosaini M; Walter JS; Singh S; Dieter RS; Hsieh A; Leehey DJ
    Am J Nephrol; 2014; 39(3):204-9. PubMed ID: 24577494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
    Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
    Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
    Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
    Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
    Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
    PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients.
    Rosa-Diez G; Negri AL; Crucelegui MS; Philippi R; Perez-Teysseyre H; Sarabia-Reyes C; Loor-Navarrete H; Heguilen R
    Clin Kidney J; 2016 Jun; 9(3):481-5. PubMed ID: 27274837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
    Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
    Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review.
    Varghese A; Lacson E; Sontrop JM; Acedillo RR; Al-Jaishi AA; Anderson S; Bagga A; Bain KL; Bennett LL; Bohm C; Brown PA; Chan CT; Cote B; Dev V; Field B; Harris C; Kalatharan S; Kiaii M; Molnar AO; Oliver MJ; Parmar MS; Schorr M; Shah N; Silver SA; Smith DM; Sood MM; St Louis I; Tennankore KK; Thompson S; Tonelli M; Vorster H; Waldvogel B; Zacharias J; Garg AX;
    Can J Kidney Health Dis; 2020; 7():2054358120964078. PubMed ID: 33149925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Observation of Serum Total Magnesium Level in Patients Undergoing Hemodialysis.
    Yang W; Wang E; Chen W; Chen C; Chen S
    Blood Purif; 2021; 50(2):196-204. PubMed ID: 32866952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total serum and intraerythrocyte magnesium concentrations in hemodialysis patients using different dialysate solutions.
    Kusic J; Markovic R; Andjelkovic Apostolovic M; Dragovic G
    Magnes Res; 2020 May; 33(2):28-36. PubMed ID: 32900678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
    Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
    Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.
    de Francisco ALM; Varas J; Ramos R; Merello JI; Canaud B; Stuard S; Pascual J; Aljama P;
    Kidney Int Rep; 2018 Mar; 3(2):374-384. PubMed ID: 29725641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
    Okamoto T; Hatakeyama S; Hosogoe S; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
    PLoS One; 2018; 13(7):e0199160. PubMed ID: 29969455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?
    Nakamura N; Yoneda K; Higo T; Kusumoto M
    J Pharm Health Care Sci; 2022 Dec; 8(1):35. PubMed ID: 36514145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hemodialysis on serum magnesium concentration in hemodialysis patients.
    Han Z; Zhou L; Liu R; Feng L
    Ann Palliat Med; 2020 May; 9(3):1134-1143. PubMed ID: 32498528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.
    Van Ende C; Van Laecke S; Marechal C; Verbeke F; Kanaan N; Goffin E; Vanholder R; Jadoul M
    J Nephrol; 2014 Dec; 27(6):707-11. PubMed ID: 24816563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.